Judith M. M.
- Country
- Spain
- Department
- Nephrology
Research Overview
- Efficacy and Safety of Atrasentan in Patients with IgA Nephropathy Receiving Sodium-Glucose Cotransporter-2 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Colchicine and Tiemonium Methylsulphate in Secondary Prevention of Cardiovascular Events in Moderate Chronic Renal Disease Patients
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Felzartamab in Adults with IgA Nephropathy (299IG301 / PREVAIL)
Data & Insights
Has run more than one trial at 9 of 94 partner sites.
Specializations
Nephrology
The investigator specializes in studying treatments for IgA nephropathy and chronic kidney disease, with particular emphasis on innovative therapeutic approaches.
- Renal Disease Management
- Progressive Kidney Disorders
- Therapeutic Interventions in Nephrology
Their research extends to evaluating novel therapeutic agents for kidney disease treatment.
Cardiovascular Health
The investigator focuses on the intersection of cardiovascular complications and renal disease, exploring preventive treatments for patients with kidney disorders.
- Secondary Prevention Strategies
- Vascular Event Prevention
- Cardiovascular Risk Management
Their work encompasses comprehensive approaches to managing cardiovascular risks in renal patients.
Therapeutic Innovation
The investigator evaluates novel therapeutic compounds and their applications in treating complex renal conditions, including research into SGLT2 inhibitors.
- Drug Efficacy Studies
- Combined Therapy Approaches
- Treatment Optimization
Their research includes investigating combination therapies for enhanced treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.